Hyperglycemia in the critically ill: meaning and treatment;Hyperglycémie dans les maladies aiguës : signification et prise en charge

Presse Medicale

Volumn 38, Issue 4, 2009, Pages 562-570

  Schlienger, Jean Louis ^a   Pradignac, Alain ^a   Vinzio, Stéphane ^a   Luca, Florina ^a   Suna, Carmen ^a   Grunenberger, Fabienne ^a   Goichot, Bernard ^a  

^a HÔPITAL DE HAUTEPIERRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ACUTE DISEASE; CRITICALLY ILL PATIENT; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HEART INFARCTION; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN TREATMENT; MORBIDITY; MORTALITY; RISK ASSESSMENT; SEPSIS; SHORT SURVEY; STRESS; STROKE;

CRITICAL ILLNESS; ENERGY METABOLISM; HOSPITAL MORTALITY; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN; INTENSIVE CARE; MYOCARDIAL INFARCTION; PROGNOSIS; RESUSCITATION; RISK ASSESSMENT; RISK FACTORS; SEPSIS; STRESS, PHYSIOLOGICAL; STROKE; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 63449135228     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2008.07.020     Document Type: Short Survey

References (50)

1. van den Berghe G., Wouters P., Weekers F., Verwaest C., Bruyninckx F., Schetz M., et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 345 (2001) 1359-1367
2. Furnary A.P., Gao G., Grunkemeier G.L., Wu Y., Zerr K.J., Bookin S.O., et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 125 (2003) 1007-1021
3. Lazar H.L., Chipkin S.R., Fitzgerald C.A., Bao Y., Cabral H., and Apstein C.S. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation 109 (2004) 1497-1502
4. Vergès B., Zeller M., Dentan G., Beer J.C., Laurent Y., Janin-Manificat L., et al. Impact of fasting glycemia on short-term prognosis after acute myocardial infarction. J Clin Endocrinol Metab 92 6 (2007) 2136-2140
5. Suleiman M., Hammerman H., Boulos M., Kapeliovich M.R., Suleiman A., Agmon Y., et al. Fasting glucose is an important independent risk factor for 30-day mortality in patients with acute myocardial infarction: a prospective study. Circulation 111 (2005) 754-760
6. Capes S.E., Hunt D., Malmberg K., and Gerstein H.C. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 355 (2000) 773-778
7. Capes S.E., Hunt D., Malmberg K., Pathak P., and Gerstein H.C. Stress hyperglycemia and prognosis of stroke in non diabetic and diabetic patients: a systematic overview. Stroke 32 (2001) 2426-2432
8. Bruno A., Levine S.R., Frankel M.R., Brott T.G., Lin Y., Tilley B.C., Lyden P.D., Broderick J.P., Kwiatkowski T.G., Fineberg S.E., and NINDS rt-PA Stroke Study Group. Admission glucose level and clinical outcomes in the NINDSrt-PA Stroke Trial. Neurology 59 (2002) 669-674
9. Williams L.S., Rotich J., Qi R., Fineberg N., Espay A., and Bruno A. Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke. Neurology 59 (2002) 67-71
10. Krinsley J.S. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc 78 (2003) 1471-1478
11. Wanek S., and Wolf S.E. Metabolic response to injury and role of anabolic hormones. Cur Opin Nutr Metab Care 10 (2007) 272-277
12. Montagnani M., Golovchenko I., Kim I., Koh G.Y., Goalstone M.L., Mundhekar A.N., et al. Inhibition of phosphatidyl inositol 3-kinase enhances mitogenic actions of insulin in endothelial cells. J Biol Chem 277 (2002) 1794-1799
13. Duska F., and Andel M. Intensive blood glucose in acute and prolonged critical illness: endogenous secretion contributes more to plasma insulin than exogenous insulin infusion. Metabolism 57 (2008) 669-671
14. Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M, F et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in human: role of oxidative stress. Circulation 2002; 106:2067-72.
15. Langouche L., Vanhorebeek I., and Vlasselaers D. Intensive insulin therapy protects the endothelium of critically ill patients. J Clin Invest 115 (2005) 2277-2286
16. Kersten J.R., Schmeling T.J., Orth K.G., Pagel P.S., and Warltier D.C. Acute hyperglycemia abolishes ischemic preconditioning in vivo. Am J Physiol Heart Circ Physiol 247 (1998) H721-H725
17. Devos P., Chioléro R., Van den Berghe G., and Preiser J.C. Glucose, insulin and myocardial ischaemia. Cur Opin Clin Nutr Metab Care 9 (2006) 131-139
18. Fath-ordoubadi F., and Beatt K.J. Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials. Circulation 96 (1997) 1152-1156
19. Langouche L., Perre S.V., D'hoore A., Hansen T.K., and Van Den Berghe G. Effect of intensive insulin therapy on insulin sensitivity in the critically ill. J Clin Endocrinol Metab 92 (2007) 3890-3897
20. Takala J., Ruokonen E., Webster N.R., Nielsen M.S., Zandstra D.F., Vundelinckx G., and Hinds C.J. Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 341 (1999) 785-792
21. Herndon D.N., Ramzy P.I., DebRoy M.A., Zheng M., Ferrando A.A., Chinkes D.L., et al. Muscle protein catabolism after severe burn: effects of IGF-1/GFBP-3 treatment. Ann Surg 229 (1999) 713-722
22. Ferrando A.A., Chinkes D.L., Wolf S.E., Matin S., Herndon D.N., and Wolfe R.R. A submaximal dose of insulin promotes net skeletal muscle protein synthesis in patients with severe burns. Ann Surg 229 (1999) 11-18
23. Thomas S.J., Morimoto K., Herndon D.N., Ferrando A.A., Wolfe R.R., Klein G.L., and Wolf S.E. The effect of prolonged euglycemic hyperinsulinemia on lean body mass after severe burn. Surgery 132 (2002) 341-347
24. Demling R.H., and De Santi L. Oxandrolone, an anabolic steroid, significantly increases the rate of weight gain in the recovery phase after major burns. J Trauma 43 (1997) 47-51
25. Van den Berghe G., Wilmer A., Hermans G., Meersseman W., Wouters P.J., Milants I., et al. Intensive insulin therapy in the medical ICU. N Engl J Med 354 (2006) 449-461
26. Krinsley J.S. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc 79 (2004) 992-1000
27. Vanhorebeek I., De Vos R., Mesotten D., Wouters P.J., De Wolf-Peeters C., and Van Den Berghe G. Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients. Lancet 365 (2005) 53-59
28. Ellger B., Debaveye Y., Vanhorebeek I., Langouche L., Giulietti A., Van Etten E., et al. Survival benefits of intensive insulin therapy in critical illness: impact of maintaining normoglycemia versus-independent actions of insulin. Diabetes 55 (2006) 1096-1105
29. Weekers F., Giulietti A.P., Michalaki M., Coopmans W., Van Herck E., Mathieu C., and Van den Berghe G. Metabolic, endocrine, and immune effects of stress hyperglycemia in a rabbit model of prolonged critical illness. Endocrinology 144 (2003) 5329-5338
30. Van den Berghe G., Wilmer A., Milants I., Wouters P.J., Bouckaert B., Bruyninckx F., Bouillon R., and Schetz M. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes 55 (2006) 3151-3159
31. Rovlias A., and Kotsou S. The influence of hyperglycemia on neurological outcome in patients with severe head injury. Neurosurgery 46 (2000) 335-342
32. Bochicchio G.V., Sung J., Joshi M., Bochicchio K., Johnson S.B., Meyer W., and Scalea T.M. Persistent hyperglycemia is predictive of outcome in critically ill trauma patients. J Trauma 58 (2005) 921-924
33. Mehta S.R., Yusuf S., Díaz R., Zhu J., Pais P., Xavier D., Paolasso E., Ahmed R., Xie C., Kazmi K., Tai J., Orlandini A., Pogue J., Liu L., and CREATE-ECLA Trial Group Investigators. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. JAMA 293 (2005) 437-446
34. Malmberg K., Rydén L., Efendic S., Herlitz J., Nicol P., Waldenström A., Wedel H., and Welin L. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol 26 (1995) 57-65
35. Cheung N.W., Wong V.W., and Mc Lean M. The hyperglycemia: Intensive Insulin Infusion in infarction (HI-5) study: a randomized controlled trial of insulin infusion therapy for myocardial infarction. Diabetes Care 29 (2006) 765-770
36. Malmberg K., Rydén L., Wedel H., Birkeland K., Bootsma A., Dickstein K., Efendic S., Fisher M., Hamsten A., Herlitz J., Hildebrandt P., MacLeod K., Laakso M., Torp-Pedersen C., Waldenström A, and DIGAMI 2 Investigators. Intensive metabolic control by means of insulin in patients with diabetic mellitus and acute myocardial infarction (DIGAM'S): effects on mortality and morbidity. Eur Heart J 26 (2005) 650-661
37. Mellbin L.G., Malmberg K., Norhammar A., Wedel H., Rydén L., and DIGAMI 2 Investigators. The impact of glucose lowering treatment on long-term prognosis in patients with type 2 diabetes and myocardial infartion: a report from the DIGAMIZ trial. Eur Heart J 29 (2008) 166-176
38. Danchin N., Charpentier G., Ledru F., Vaur L., Gueret P., Hanania G., et al. Role of previous treatment with sulfonylveas in diabetic patients with acute myocardial infarction: results from a nationwide French registry. Diabetes Metab Res Rev 21 (2005) 143-149
39. Hamilton M.G.G., Tranmer B.I., and Auer R.N. Insulin reduction of cerebral infarction due to transient focal ischemia. J Neurosurg 82 (1995) 262-268
40. Zhu C.Z., and Auer R.N. Optimal blood glucose levels while using insulin to minimize the size of infarction in focal cerebral ischemia. J Neurosurg 101 (2004) 664-668
41. Van Den Berghe G., Schoonheydt K., Becx P., Bruyninckx F., and Wouters P.J. Insulintherapy protects the central and peripheral nervous system of intensive care patients. Neurology 64 (2005) 1348-1353
42. Ingels C., Debaveye Y., Milants I., Buelens E., Peeraer A., Devriendt Y., Vanhoutte T., et al. Strict blood glucose control with insulin during intensive care after cardiac surgery: impact on 4-years survival, dependency on medical care, and quality-of-life. Eur Heart J 27 (2006) 2716-2724
43. Ferris F.L., Davis M.D., and Aiello L.M. Treatment of diabetic retinopathy. N Engl J Med 341 (1999) 667-678
44. Gandhi G.Y., Nuttall G.A., Abel M.D., Mullany C.J., Schaff H.V., O'Brien P.C., et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery. Ann Inter Med 146 4 (2007) 233-243
45. Brunkhorst F.M., Engel C., Bloos F., Meier-Hellmann A., Ragaller M., Weiler N., et al. Intensive insulin therapy and Pentasarch resuscitation in severe sepsis. N Engl J Med 358 (2008) 125-139
46. Mesotten D., Swinnen J.V., Vanderhoydonc F., Wouters P.J., and Van den Berghe G. Contribution of circulating lipids to the improved outcome of critical illness by glycaemic control with intensive insulin therapy. J Clin Endocrinol Metab 90 (2004) 2219-2226
47. Brunkhorst F.M., and Schortgen F. Intensive insulin therapy in the ICU: benefit versus harm ?. Intensive Care 33 (2007) 1302
48. Vriesendorp T.M., Devries J.H., and Van Stanten S. Evaluation of short-term consequences of hypoglycemia in an intensive care unit. Crit Care Med 34 (2006) 2714-2718
49. Vespa P., Boonyaputthikul R., McArthur D.L., Miller C., Etchepare M., Bergsneider M., et al. Intensive insulin therapy reduces microdialysis glucose values without altering glucose utilization or improving lactate/pyruvate ratio after brain injury. Crit Care Med 34 (2006) 850-856
50. Mebis L., Gunst J., Langouche L., Vanhorebeek I., and Van den Berghe G. Indication and practical use of intensive insulin therapy in the critically ill. Curr Opin Crit Care 13 (2007) 392-398